Here we'll hash out the differences among cannabis players and see high how Roundhill Investment's The Cannabis ETF can go.
Pressure on fertilizer supplies due to sanctions against Russia because of the war in Ukraine makes the potash producer a star performer in a down market.
Tilray is okay in my book for speculation.
There should be some better trading action and setups as things pull back.
It isn't brave to trade without a game plan; it's foolhardy and can result in big losses.
Small-caps and growth names are relatively weak.
Let's check out the 21-day exponential moving averages of SPY and QQQ for clues and also look at three stocks for trading ideas.
While performance hasn't been mind blowing so far, psychedelics are where cannabis was a decade or so ago.
I'm looking at a possible inverse head and shoulders forming on many cannabis charts.
Yet there's good relative strength in biotech, growth, cannabis, small-caps, and other sectors that have been the biggest laggards.